Literature DB >> 17852819

Body weight and oral contraceptives are the most important modulators of serum CRP levels.

S Buchbinder1, J Kratzsch, G M Fiedler, V Yar, M Brügel, A Leichtle, W Weber, H Alexander, G Matthes, J Thiery.   

Abstract

BACKGROUND: C-reactive protein (CRP) levels are modulated by endogenous and exogenous factors independently of inflammation. The present study investigated the impact of oral contraceptives, endogenous oestrogens, age, gender, smoking, body mass index (BMI) and lipid levels on CRP concentrations in a healthy collective.
METHODS: Highly sensitive CRP, total cholesterol, HDL-cholesterol and LDL-cholesterol levels were measured in 850 blood donors (438 M, 412 F); 227 women in this group used oral contraceptive formulations (OC). Additionally, serum samples from 58 women undergoing in vitro fertilization cycles (IVF) were tested for CRP. Results. The 97.5th percentile of CRP levels of the blood donors was 4.91 mg/L in men, 7.52 mg/L in OC non-users and 11.95 mg/L in OC users. Overweight gives a 2-fold increase of median CRP levels in men and women. The combination of overweight and OC use in women resulted in 6-fold median CRP levels. Age, smoking and lipid levels were influencing factors of lower significance. In IVF patients the elevated oestradiol levels had no influence on CRP concentrations in multivariance analysis.
CONCLUSION: The diagnostic and predictive value of CRP levels is most affected by BMI and oral contraceptive use, which suggests the need for further investigations into the role of CRP modulating factors in monitoring infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852819     DOI: 10.1080/00365510701487727

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  10 in total

1.  Change in high-sensitivity c-reactive protein levels following initiation of efavirenz-based antiretroviral regimens in HIV-infected individuals.

Authors:  Cecilia M Shikuma; Heather J Ribaudo; Yu Zheng; Roy M Gulick; William A Meyer; Karen T Tashima; Barbara Bastow; Daniel R Kuritzkes; Marshall J Glesby
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

2.  Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.

Authors:  Grace A McComsey; Douglas Kitch; Eric S Daar; Camlin Tierney; Nasreen C Jahed; Kathleen Melbourne; Belinda Ha; Todd T Brown; Anthony Bloom; Neal Fedarko; Paul E Sax
Journal:  AIDS       Date:  2012-07-17       Impact factor: 4.177

3.  Psychiatric symptoms are not associated with circulating CRP concentrations after controlling for medical, social, and demographic factors.

Authors:  Jonathan Savitz; Martin P Paulus; Leandra K Figueroa-Hall; Bohan Xu; Rayus Kuplicki; Bart N Ford; Kaiping Burrows; T Kent Teague; Sandip Sen; Hung-Wen Yeh; Michael R Irwin
Journal:  Transl Psychiatry       Date:  2022-07-12       Impact factor: 7.989

4.  [C-reactive protein. An independent risk factor for the development of infection after primary arthroplasty].

Authors:  T Pfitzner; D Krocker; C Perka; G Matziolis
Journal:  Orthopade       Date:  2008-11       Impact factor: 1.087

5.  Host and Environmental Factors Influencing Individual Human Cytokine Responses.

Authors:  Rob Ter Horst; Martin Jaeger; Sanne P Smeekens; Marije Oosting; Morris A Swertz; Yang Li; Vinod Kumar; Dimitri A Diavatopoulos; Anne F M Jansen; Heidi Lemmers; Helga Toenhake-Dijkstra; Antonius E van Herwaarden; Matthijs Janssen; Renate G van der Molen; Irma Joosten; Fred C G J Sweep; Johannes W Smit; Romana T Netea-Maier; Mieke M J F Koenders; Ramnik J Xavier; Jos W M van der Meer; Charles A Dinarello; Norman Pavelka; Cisca Wijmenga; Richard A Notebaart; Leo A B Joosten; Mihai G Netea
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

6.  Effect of oral and vaginal hormonal contraceptives on inflammatory blood biomarkers.

Authors:  Afshin A Divani; Xianghua Luo; Yvonne H Datta; James D Flaherty; Angela Panoskaltsis-Mortari
Journal:  Mediators Inflamm       Date:  2015-03-16       Impact factor: 4.711

7.  Obesity, coffee consumption and CRP levels in postmenopausal overweight/obese women: importance of hormone replacement therapy use.

Authors:  B J Arsenault; C P Earnest; J-P Després; S N Blair; T S Church
Journal:  Eur J Clin Nutr       Date:  2009-09-16       Impact factor: 4.016

8.  C-reactive protein in adult Samoans: Population variation and physiological correlates.

Authors:  Anna C Rivara; Margaret Corley; Courtney C Choy; Rachel L Duckham; Alysa Pomer; Muagututia Sefuiva Reupena; Satupaitea Viali; Take Naseri; Erin E Kershaw; Scott E Crouter; Stephen T McGarvey; Richard G Bribiescas; Claudia Valeggia; Nicola L Hawley
Journal:  Am J Hum Biol       Date:  2021-07-14       Impact factor: 1.937

9.  Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: results from the Danish Blood Donor Study (DBDS).

Authors:  Cecilie J Sørensen; Ole B Pedersen; Mikkel S Petersen; Erik Sørensen; Sebastian Kotzé; Lise W Thørner; Henrik Hjalgrim; Andreas S Rigas; Bjarne Møller; Klaus Rostgaard; Mads Riiskjær; Henrik Ullum; Christian Erikstrup
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

10.  A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition.

Authors:  Ernst Mayerhofer; Franz Ratzinger; Nina Elvira Kienreich; Annika Stiel; Nadine Witzeneder; Eva Schrefl; Georg Greiner; Christoph Wegscheider; Irene Graf; Klaus Schmetterer; Rodrig Marculescu; Thomas Szekeres; Thomas Perkmann; Martina Fondi; Oswald Wagner; Harald Esterbauer; Matthias Mayerhofer; Stefana Holocher-Ertl; Claudia Wojnarowski; Gregor Hoermann
Journal:  Front Pediatr       Date:  2020-02-21       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.